Since 2012/13, Venezuela has experienced a rapid deterioration of the public health situation due to an ongoing political and economic crisis \[[@r1]\]. This crisis has led to the collapse of the healthcare system, resulting in the re-emergence of previously controlled or eliminated communicable diseases and to the lack of proper provision of sanitation, goods, services and food security \[[@r2],[@r3]\]. In March--April 2019, recurrent and prolonged electricity blackouts in large parts of the country affected the availability of running water, telecommunication within and outside the country, transportation, adequate food cooling (e.g. fridge/freezers), economic mobility and education \[[@r4]\]. The healthcare sector was affected by the closure of operating theatres and emergency rooms, lack of care for chronic patients requiring medical devices for their survival and lack of medicines and vaccines \[[@r4]\].

Here, we present the latest available information on communicable diseases in Venezuela and the possible implications that it may have in the European Union and European Economic Area (EU/EEA), hereafter referred to as Europe.

Status of communicable diseases in Venezuela
============================================

In December 2016, the latest national report on communicable diseases was published by the Venezuelan Ministry of Health \[[@r5]\], in which an increase in infant and maternal mortality, a resurgence of diphtheria and an increase in the incidence of malaria, Zika, tuberculosis and hepatitis A was reported. The current situation of communicable diseases in Venezuela is available from reports from the World Health Organization (WHO), scientific research and studies/surveys on specific pathogens. Most of these sources acknowledge a noticeable gap between the reported and the estimated incidence or prevalence of some communicable diseases, thus the numbers in Table 1 demonstrate only confirmed cases and should be read with caution of possible underestimation ([Table 1](#t1){ref-type="table"}).

###### Latest available data on confirmed cases of communicable diseases and associated deaths in Venezuela, by disease and time period

  Disease                            Time period             Confirmed cases   Deaths                          Source
  ---------------------------------- ----------------------- ----------------- ------------------------------- -------------------------------
  **Vaccine preventable diseases**                                                                             
  **Diphtheria**                     W26 2016--W08 2019^a^   1,612             280                             PAHO \[[@r16]\]
  **Measles**                        W26 2017--W52 2017^a^   727               2                               PAHO \[[@r6]\]
  2018                               5,667                   74                PAHO \[[@r6]\]                  
  W01 2019--W13 2019^b^              140                     NA                PAHO \[[@r6]\]                  
  **Mosquito-borne diseases**                                                                                  
  **Chikungunya**                    2014                    2,303             0                               PAHO \[[@r17]\]
  2015                               347                     0                 PAHO \[[@r17]\]                 
  2016                               355                     0                 PAHO \[[@r17]\]                 
  2017                               39                      0                 PAHO \[[@r17]\]                 
  **Dengue**                         2016                    5,833             39                              PAHO \[[@r18]\]
  2017                               1,588                   16                PAHO \[[@r18]\]                 
  2018                               2,440                   24                PAHO \[[@r18]\]                 
  W01 2019--W17 2019^b^              288                     8                 PAHO \[[@r18]\]                 
  **Malaria**                        2016                    240,613           NA                              WHO \[[@r9]\]
  2017                               414,000                 NA                WHO \[[@r9]\]                   
  **Zika**                           2016                    2,380             0                               PAHO \[[@r19]\]
  2017                               2,413                   0                 PAHO \[[@r19]\]                 
  **Other vector-borne diseases**                                                                              
  **Chagas**                         Oct 2017--Apr 2018^a^   40                8                               Grillet et al. 2019 \[[@r7]\]
  **Oral Chagas disease**            May 2016^a^             5                 0                               Grillet et al. 2019 \[[@r7]\]
  Sep 2017^a^                        6                       3                 Grillet et al. 2019 \[[@r7]\]   
  Mar 2018                           42                      6                 Grillet et al. 2019 \[[@r7]\]   
  **Cutaneous leishmaniasis**        1990--2016^a^           61,576            NA                              Grillet et al. 2019 \[[@r7]\]
  2014                               Ca 1,750                NA                Grillet et al. 2019 \[[@r7]\]   
  2015                               Ca 2,000                NA                Grillet et al. 2019 \[[@r7]\]   
  2016                               Ca 2,000                NA                Grillet et al. 2019 \[[@r7]\]   
  **HIV and tuberculosis**                                                                                     
  **HIV**                            2016                    120,000^c^        2,500                           UNAIDS \[[@r20]\]
  **Tuberculosis**                   2017                    10,952^c^         800                             WHO \[[@r21]\]

HIV: human immunodeficiency virus; NA: not available; PAHO: Pan American Health Organisation; WHO: World Health Organization.

^a^Time period corresponding to an outbreak.

^b^Incomplete year.

^c^These are prevalent confirmed cases.

Only confirmed cases are reported in Table 1. There may be a possible underestimation of cases; therefore, numbers should be interpreted with caution.

Vaccine preventable diseases
----------------------------

Diphtheria and measles have re-emerged due to vaccine shortages and lack of vaccination programmes, in July 2016 and in 2017, respectively. Between 2016 and 2018, there have been 280 deaths from diphtheria. In 2018, there were over 5,000 confirmed measles cases, with 10% of the cases affecting indigenous populations in Amazonas and Delta Amacuro states \[[@r6]\].

Mosquito-borne diseases
-----------------------

Arboviruses, e.g. dengue, chikungunya and Zika virus, are an expanding threat in the country \[[@r7]\]. Due to interruptions of water supply and electricity, residents in Venezuela have to store water in receptacles that maintain favourable breeding conditions for *Aedes* mosquitoes. In addition, there is an increased possibility of severe dengue cases due to co-circulation of four dengue virus serotypes (DENV 1--4) \[[@r8]\]. Epidemics of chikungunya in 2014 and Zika virus in 2015--16 reported in Latin America also impacted the country with a high number of cases ([Table 1](#t1){ref-type="table"}).

Confirmed cases of malaria increased between 2016 and 2017, with 240,613 detected in 2016 and 414,000 malaria cases in 2017 -- the highest annual total recorded since 1988 \[[@r9]\]. It has been estimated that there were one million malaria cases in 2018, including non-reported infections and relapses \[[@r10]\]. The surveillance programme against malaria has been gradually dismantled since 2012 \[[@r11]\].

Other vector-borne diseases
---------------------------

Additional vector-borne diseases have been reported in the country. The seroprevalence of *Trypanosoma cruzi,* which causes Chagas disease, has increased in recent decades following decentralisation of control measures in 1990s and after the Chagas diseases programme was dismantled in 2012 \[[@r7]\]. Between October 2017 and April 2018 there were 40 confirmed cases of Chagas disease ([Table 1](#t1){ref-type="table"}). Leishmaniasis is widespread in the human and animal population, outbreaks of Mayaro virus have been reported in the past decade, Oropouche virus in the Amazonas state and the occurrence of epizootic strains of Venezuelan equine encephalitis \[[@r7]\].

HIV and tuberculosis
--------------------

The latest available information on cases of HIV and tuberculosis from 2016 and 2017, respectively, can be seen in [Table 1](#t1){ref-type="table"}. The incidence rate of tuberculosis is the highest reported in the country for the past 40 years \[[@r12]\], with more than 10,000 confirmed cases in 2017 ([Table 1](#t1){ref-type="table"}).

Asylum seekers and travellers returning from Venezuela
======================================================

An increased emigration of Venezuelan nationals has been reported since 2014 \[[@r7]\]. There were ca 1,750,000 Venezuelans reported to be seeking asylum between January and June 2018, 46% of whom applied for asylum in Peru, Ecuador or Colombia ([Figure 1](#f1){ref-type="fig"}) \[[@r13]\].

![Geographic distribution of asylum seekers from Venezuela by country of asylum, January--June 2018 (n = 1,750,000)](1900308-f1){#f1}

In Europe, the number of Venezuelan asylum seekers increased from ca 320 in 2014 to more than 20,000 in 2018, with almost all applications being filed in five countries (Spain, Italy, France, Germany and Belgium) and ca 85% of these in Spain ([Figure 1](#f1){ref-type="fig"}) \[[@r14]\]. According to the latest data from the European Asylum Support Office, there were ca 6,600 Venezuelan nationals applying for asylum in Europe in January--February 2019 \[[@r14]\].

In addition, there were ca 150,000 travellers returning from Venezuela to Europe in 2017, according to the International Air Transport Association (IATA) ([Figure 2](#f2){ref-type="fig"}). Of these, 87% were returning to Spain, Portugal or Italy. The available data show the country of departure and destination of the air travel, but not the nationality of the travellers.
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Discussion and conclusions
==========================

As a consequence of political and economic crisis, Venezuela faces a re-emergence of communicable diseases that were previously eliminated or controlled. Increasing numbers of people are affected by an increased incidence of infectious diseases (and outbreaks) and mortality, which may be underestimated in the absence of proper surveillance and lack of treatment; thus, the magnitude of the outbreaks may be larger than presented. In addition, the mass departure of trained medical personnel reported in recent years is having an impact on the proper care of patients \[[@r7]\]. People with chronic health conditions, pregnant and nursing women, children under 5 years, indigenous population, people without a fixed residence and those living with disabilities are among the most vulnerable \[[@r12]\].

The migration of people from Venezuela to neighbouring countries and to Europe requires increased awareness that Venezuelans (in particular the aforementioned risk groups) are facing heightened infectious disease risks and that there is a need for appropriate investigation and treatment by healthcare providers in the receiving countries.

The situation in Venezuela and travel to and from the country increases the possibility for European citizens of being exposed to circulating infectious diseases. Previous outbreaks in neighbouring and European countries have been shown to have originated from Venezuela, such as a Chagas disease outbreak in Colombia in 2017--18 \[[@r7]\] and dengue outbreak in Madeira in 2012 \[[@r15]\].

The deterioration in public health systems e.g. vaccination programmes in Venezuela also means that migrants to Europe may be at risk from diseases present in Europe, such as measles. Therefore, Venezuelan migrants residing in Europe should be recommended to seek advice from healthcare providers on vaccination requirements in the country of residence. They should also be advised to seek immediate medical advice and mention that they have recently arrived from Venezuela in case of symptoms suggestive of gastrointestinal, respiratory, cutaneous or any other type of infection. The travellers visiting Venezuela should be appropriately vaccinated, follow good hygiene practices, practice safe sex and use preventive measures against mosquito bites to prevent vaccine-preventable diseases such as measles, food- and water-borne diseases, sexually transmitted infections such as HIV and mosquito-borne diseases such as dengue or malaria, among others. Currently, the overall risk for severe diseases is considered low for European residents and returning travellers from Venezuela if public health advice is followed.
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